Safety and Efficacy of CLS-TA by Anatomic Location of Inflammation: Results from the Phase 3 PEACHTREE Clinical Trial.

Milan ShahThomas AlbiniQuan NguyenCharles WykoffMark BarakatRahul N KhuranaBarry KapikThomas A Ciulla

Published in: Ocular immunology and inflammation (2024)

Irrespective of the uveitic anatomic subtype among patients treated for ME associated with NIU, a clinical benefit in participants treated with CLS-TA was demonstrated, with a comparable safety profile.

Keyphrases

clinical trial
oxidative stress
open label
double blind
newly diagnosed